Our research group at Southampton contains a combination of non-clinical researchers as well as CAM and conventional clinicians who have become researchers. The transition from practitioner to practitioner-researcher has led us to question, challenge and re-consider the paradigmatic differences in our practices compared to conventional medicine and how we might understand and interpret evidence derived from both quantitative and qualitative research. We very much value the randomised controlled trial (RCT) but have all come to understand its limitations and constraints when trying to encapsulate a complete, rigorous, and honest understanding of our complex interventions and how they are delivered in practice. Equally, our expertise in qualitative research leads us to understand the patient’s perspective and to value a more individual agenda. We believe that we share these tensions with clinicians working in primary care. We appreciate that we need to understand contextual effects so we can better utilise and research them appropriately, rather than dismiss them as mere placebo. These issues represent both personal and transcendent conflicts that we have expressed as a series of vignettes each written by a practitioner/researcher working in that filed. Our principle aim in writing this essay is to offer our practical experience and insight as issues for thoughtful debate for those clinicians and academics involved in clinical research in controversial areas such as CAM.
Dr. George Lewith, Professor of Health Research, University of Southampton, Complementary and Integrated Medicine Research Unit, Primary Medical Care, Aldermoor Health Centre, Aldermoor Close, Southampton SO16 5ST, UK, Tel. +44 2380 241073, Fax 701125, email@example.com
Published_online: September 10, 2009
Number of Print Pages : 5
Forschende Komplementärmedizin / Research in Complementary Medicine (Research Practice Perspectives - Wissenschaft Praxis Perspektiven)
Vol. 16, No. 5, Year 2009 (Cover Date: November 2009)
Journal Editor: Walach H. (Northampton)
ISSN: 1661-4119 (Print), eISSN: 1661-4127 (Online)
For additional information: http://www.karger.com/FOK
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.